atripla
Pharmaranks rates Atripla 3.5/5 for recall safety — an independent score from its FDA recall history and its manufacturer's record. Atripla is a combination medicine containing Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate.
Efavirenz and Emtricitabine and Tenofovir Disoproxil Fumarate · by Gilead Sciences Inc
Based on 1 source · Recall-safety score from FDA recall history — this product's own recalls and its manufacturer's record. Not an efficacy or quality rating. methodology →
Key facts
- Active ingredient
- Efavirenz and Emtricitabine and Tenofovir Disoproxil Fumarate
- Form
- Tablet
- Strength
- Efavirenz 600MG; Emtricitabine 200MG; Tenofovir Disoproxil Fumarate 300MG **Federal Register Determination That Product was not Discontinued or Withdrawn for Safety or Effectiveness reasons**
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- Manufacturer
- Gilead Sciences Inc
- What the pharmacy pays
- ~$42.28 for 30 — not your price
- FDA application
- NDA021937
- Availability
- Discontinued (per FDA)
Dosage forms
Tablet
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- How is Atripla rated?
- pharmaranks gives Atripla a composite score of 3.5 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.
- How much does Atripla cost?
- Nobody can tell you what you will pay — your price is set by your insurer's formulary, your deductible and the pharmacy's markup, and none of those are published. What IS published is what the pharmacy paid to acquire it: about $42.28 for 30, per the CMS NADAC survey. Treat that as the floor, not the quote — ask the pharmacist for the cash price as well as your copay, because for cheap generics the cash price often wins. Pharmacies pay less for a same-class option, Abiraterone Acetate — about $25.50 on the same basis.
- Is there a coupon or discount for Atripla?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Atripla. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Atripla?
- Atripla is marketed by Gilead Sciences Inc. You can see Gilead Sciences Inc's full profile, rating, and other products on pharmaranks.
- Is Atripla a brand-name or generic drug?
- Atripla is a brand-name product with the active ingredient Efavirenz and Emtricitabine and Tenofovir Disoproxil Fumarate.
- Is Atripla available over the counter?
- No. Atripla is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Atripla come in?
- Atripla is currently marketed as tablet, per the FDA's National Drug Code Directory.
- Is Atripla FDA-registered?
- Atripla is on record with the U.S. FDA under application number NDA021937. You can verify this on its official FDA label.
- Has Atripla been recalled by the FDA?
- Atripla has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.
- Is Atripla safe?
- There's no single safe-or-not verdict. pharmaranks gives Atripla a recall-safety score of 70/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
Reviews
No reviews yet. Be the first to write one.
People also viewed
abiraterone acetate
Abiraterone Acetate
acular
Ketorolac Tromethamine
acular ls
Ketorolac Tromethamine
aimovig
Erenumab-Aooe
albendazole
Albendazole
alphagan p
Brimonidine Tartrate
Compare Atripla head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
atripla
70/100